Viewing Study NCT00895960


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-27 @ 11:36 PM
Study NCT ID: NCT00895960
Status: TERMINATED
Last Update Posted: 2018-11-08
First Post: 2009-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module